Capecitabine-induced cardiotoxicity mimicking myocardial infarction
dc.contributor.buuauthor | Şentürk, Tunay | |
dc.contributor.buuauthor | Kanat, Özkan | |
dc.contributor.buuauthor | Evrensel, Türkkan | |
dc.contributor.buuauthor | Aydınlar, Ali | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-8974-8837 | tr_TR |
dc.contributor.researcherid | C-1517-2017 | tr_TR |
dc.contributor.researcherid | AAI-6632-2021 | tr_TR |
dc.contributor.scopusid | 8342098300 | tr_TR |
dc.contributor.scopusid | 55881548500 | tr_TR |
dc.contributor.scopusid | 6603942124 | tr_TR |
dc.contributor.scopusid | 6603131517 | tr_TR |
dc.date.accessioned | 2021-12-09T08:01:59Z | |
dc.date.available | 2021-12-09T08:01:59Z | |
dc.date.issued | 2009-08 | |
dc.description.abstract | Capecitabine, a fluoropyrimidine derivative, is an orally administered drug that delivers 5-fluorouracil (5-FU) selectively to the tumour. The drug has demonstrated activity in metastatic colorectal cancer. We describe a male patient receiving capecitabine therapy with typical chest pain and electrocardiographic changes consistent with ST-segment elevation myocardial infarction. Capecitabine-induced cardiotoxicity may develop in patients who have had a previous episode of 5-FU-induced cardiotoxicity. Capecitabine-induced cardiotoxicity is a rare condition that may lead to diagnostic and therapeutic dilemmas. | en_US |
dc.identifier.citation | Şentürk, T. vd. (2009). "Capecitabine-induced cardiotoxicity mimicking myocardial infarction". Netherlands Heart Journal, 17(7-8), 277-280. | en_US |
dc.identifier.endpage | 280 | tr_TR |
dc.identifier.issn | 1568-5888 | |
dc.identifier.issue | 7-8 | tr_TR |
dc.identifier.pubmed | 19789694 | tr_TR |
dc.identifier.scopus | 2-s2.0-70349283313 | tr_TR |
dc.identifier.startpage | 277 | tr_TR |
dc.identifier.uri | https://doi.org/10.1007/BF03086265 | |
dc.identifier.uri | https://link.springer.com/article/10.1007%2FBF03086265 | |
dc.identifier.uri | http://hdl.handle.net/11452/23117 | |
dc.identifier.volume | 17 | tr_TR |
dc.identifier.wos | 000269178900004 | |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bohn Stafleu van Loghum | en_US |
dc.relation.journal | Netherlands Heart Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Capecitabine | en_US |
dc.subject | Cardiotoxicity | en_US |
dc.subject | Myocardial infarction | en_US |
dc.subject | Cardiovascular system & cardiology | en_US |
dc.subject.emtree | Capecitabine | en_US |
dc.subject.emtree | Diltiazem | en_US |
dc.subject.emtree | Fluorouracil | en_US |
dc.subject.emtree | Folinic acid | en_US |
dc.subject.emtree | Isosorbide mononitrate | en_US |
dc.subject.emtree | Oxaliplatin | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cancer adjuvant therapy | en_US |
dc.subject.emtree | Cardiotoxicity | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Clinical feature | en_US |
dc.subject.emtree | Continuous infusion | en_US |
dc.subject.emtree | Differential diagnosis | en_US |
dc.subject.emtree | Drug effect | en_US |
dc.subject.emtree | Heart infarction | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Rectum carcinoma | en_US |
dc.subject.emtree | ST segment elevation | en_US |
dc.subject.emtree | Symptom | en_US |
dc.subject.emtree | Thorax pain | en_US |
dc.subject.scopus | Capecitabine; Cardiotoxicity; Coronary Artery Spasm | en_US |
dc.subject.wos | Cardiac & cardiovascular systems | en_US |
dc.title | Capecitabine-induced cardiotoxicity mimicking myocardial infarction | en_US |
dc.type | Article | |
dc.wos.quartile | Q3 | en_US |